ARCHIVES

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

May 16, 1997

In Brief: ACS Board Names McGinnis Prsident; Fuller Re-Elected chairman; Lenhard Is Vice President

November 25, 1994

Funding Opportunities: ACS Calif. Division Calls for Applications

August 1, 1997

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011

Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head.

September 9, 2005

NCI Begins PLCO Screening Trial

November 26, 1993